Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed and Carboplatin in Recurrent Ovarian Cancer
NCT01001910Phase 2Completed
- Sponsor
- Albert Einstein College of Medicine
- Start
- Jul 2008
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in ovarian carcinoma, primary peritoneal carcinoma (PPC), fallopian tube carcinoma (PFTC), sponsored by Albert Einstein College of Medicine. Started Jul 2008; status: completed.
02
Drugs
pemetrexed
03
Conditions
ovarian carcinomaprimary peritoneal carcinoma (PPC)fallopian tube carcinoma (PFTC)
Beyond the preview
Go deeper on NCT01001910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01001910.